Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises atNorth’s owners in connection with the sale to Partners Group
Mandate

Vinge advises atNorth’s owners in connection with the sale to Partners Group

January 27, 2022 M&A

Vinge has advised the shareholders of atNorth Holding AB in conjunction with the sale of the company to the Swiss private equity company Partners Group.

atNorth is a leading data centre company with two centres on Iceland and one under construction in Stockholm. The company’s data halls are run exclusively by renewable energy and use local climate and heating recycling systems in order to maintain an extremely high degree of energy efficiency.

Vinge’s team primarily consisted of partner Peter Sundgren together with associates Vilhelm Rondahl, Gustav Persson and Linus Adolfsson (M&A), Maria Schultzberg (Tax) as well as Viktoria Owetz Leyva and Sara Dahlros Sköld (VDR assistants).

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026